FindTrial
Sign In

Postoprative analgesia effect by oxycodone hydrochlorid in Gastroscopy therapy

Postoprative analgesia effect by oxycodone hydrochlorid in Gastroscopy therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008266
Enrollment
Unknown
Registered
2016-04-12
Start date
2016-04-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General surgery

Interventions

A:Sufentanil
B:oxycodone

Sponsors

Beijing YouAn Hospital, Capital Medial University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 69 Years

Inclusion criteria

Inclusion criteria: ASA status I-II, aged 20-69 years old, no restriction on gender BMI1825kg/m2?

Exclusion criteria

Exclusion criteria: Exclusion criteria were opioid drug allergy, use of monoamine oxidase inhibitor for a long time,severe hepatic and kidney disease,coagulopathy,bronchial asthma,chronic obstructive pulmonary diseases,pulmonary heart disease,intracranial hypertension,and inability to comprehend study-related procedures.

Design outcomes

Primary

MeasureTime frame
intraoperative respiratory depression;drug recruitment;—

Secondary

MeasureTime frame
visual analog scale;Total oxycodone consumption;side effect;—

Countries

China

Contacts

Public ContactZhefeng Quan

Beijing YouAn Hospital, Capital Medial University

15811190059@126.com+86 15811190059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026